7
Total investments
4
Early stage
2
Mid stage
1
Late stage
8y
Years active
Portfolio
7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Early Investor
Jun 2024
Delicity émancipe les restaurateurs des plateformes.
- Adieu les +30% de commission ! --> Delicity ne coûte que 1€/commande + coût de la livraison.
- Vous faites donc de vraies économies.💰
- Le client peut commander en direct à son restaurant ou via nos applications.
- Le prix des courses pour les coursiers indépendants est en moyenne 20% plus élevé.👏
- Les restaurateurs conservent leurs marges, le contact client et leur indépendance ! 💪
Application disponible sur lAppstore et Play Store.
Early Investor
Mar 2023
We are the industry leader in sustainable advertising AI optimization solutions. Serving the entire programmatic value chain – from advertisers and SSPs to publishers – we are committed to transforming the digital advertising landscape. We work globally with the leading advertisers, agencies and programmatic ad tech companies to drive substantial change to the advertising industry. We are active in more than 100 countries from our headquarters in Paris, France thanks to our deep integration with the main DSPs of the market. We are currently in the process of opening new offices in the UK, US and APAC. Greenbids has been backed by Elaia Partners.
Early Investor
Jan 2022
Kosmik is a next gen collaboration platform based around a fully spatial interface offering users a new way to store and manipulate their files / notes / pictures or any other media in a physical manner. It finally becomes possible to locate a precise information without diving into a complex folder hierarchy.
Kosmik can be used to brainstrom as well as to create complex documents. Once a project is done, a kosmik canvas can become a public website in a single click and without a single
Early Investor
Dec 2020
Caravel est la première plateforme entièrement dédiée à l’anticipation, la planification et lamélioration de sa retraite à laide de produits financiers éthiques et responsables qui répondent aux enjeux dun monde en perpétuel changement.
À laide de solutions transparentes, simples, pédagogiques, engagées et accessibles, nous aidons tous les individus à reprendre le contrôle de leur retraite tout en s’engageant dans une démarche sociétale et environnementale indispensable.
Entreprise à mission, nous avons été récompensés en 2021 par le prix de la meilleure fintech à impact par France Fintech.
Board Member
May 2019
Tech Lab specialized in algorithms and AI, SoyHuCe assists its customers by proposing an adequate and complete offer with its Paris and Caen teams.
SoyHuCe's approach is based on 3 areas of expertise:
- A digital factory;
- An R&D laboratory in algorithms and AI;
- A data factory
SoyHuCe positions itself on the digital and data market as a "data value enhancer". We rely on customizable software and algorithms, focusing on the business, and on its ability to bring out needs beyond those expressed through a fine analytical approach.
Founded in 2013, SoyHuCe aims to bring a new perspective to innovation. While placing people at the heart of companies, our solutions are adapted to today's economic, social and societal challenges.
Our products :
- OctoData: The ready-to-use Big Data technology orchestration platform, dedicated to the processing and enhancement of your massive data.
- iStoryPath : The webapp to generate customized tourist and event itineraries.
- AlgoRH: The intelligent planning management tool for Customer Relationship Centres.
Early Investor
Aug 2018
AlgoTx is a clinical stage biotechnology company developing targeted, first in class therapeutics for peripheral neuropathic pain.
Non-opioid, locally acting ATX01 is designed to treat the pain of Chemotherapy-Induced Peripheral Neuropathy, a common and painful side-effect of cancer treatments. It targets the signaling pathways involved in the regulation of pain by selectively inhibiting specific nociceptive sodium channel receptors. FDA granted ATX01 Fast-Track designation.
The ACT study is an international Phase II randomized, placebo-controlled trial involving over 270 patients ; The results will be available in early 2025 and the company is making plans to expedite a Phase 3 trial.
The company has seasoned leadership, with experience of bringing global products successfully to market, and is backed by an international board. AlgoTx raised a Series B round of EUR 20 million in 2023 and has raised EUR 35 million to date. AlgoTx has a consortium of investors including Relyens Innovation Santé / Turenne Capital, who led the Series B fund raise, along with UI Investissement, and angel investors. Historical investors include Bpifrance through its Innobio 2 fund and Omnes Capital.
In 2023, the company won France Biotech’s prestigious ESG HealthTech Trophy in recognition of its early commitment to ESG initiatives.
For more information, see the company’s website
Experience · 15 entries
All (15)
Investments (7)
Founder (5)
Board (1)
2025
Associé
Oct 2025
Les personnes bien guidées réussissent mieux et plus vite !
Adoptez Coptain App, créez des parcours d’accompagnement intelligents, motivants et modulables à l’infini pour libérer le potentiel des personnes dont vous avez la responsabilité !
2024
Early Investor
Jun 2024
Delicity émancipe les restaurateurs des plateformes.
- Adieu les +30% de commission ! --> Delicity ne coûte que 1€/commande + coût de la livraison.
- Vous faites donc de vraies économies.💰
- Le client peut commander en direct à son restaurant ou via nos applications.
- Le prix des courses pour les coursiers indépendants est en moyenne 20% plus élevé.👏
- Les restaurateurs conservent leurs marges, le contact client et leur indépendance ! 💪
Application disponible sur lAppstore et Play Store.
2023
Early Investor
Mar 2023
We are the industry leader in sustainable advertising AI optimization solutions. Serving the entire programmatic value chain – from advertisers and SSPs to publishers – we are committed to transforming the digital advertising landscape. We work globally with the leading advertisers, agencies and programmatic ad tech companies to drive substantial change to the advertising industry. We are active in more than 100 countries from our headquarters in Paris, France thanks to our deep integration with the main DSPs of the market. We are currently in the process of opening new offices in the UK, US and APAC. Greenbids has been backed by Elaia Partners.
2022
Early Investor
Jan 2022
Kosmik is a next gen collaboration platform based around a fully spatial interface offering users a new way to store and manipulate their files / notes / pictures or any other media in a physical manner. It finally becomes possible to locate a precise information without diving into a complex folder hierarchy.
Kosmik can be used to brainstrom as well as to create complex documents. Once a project is done, a kosmik canvas can become a public website in a single click and without a single
Show all 15 entries ↓
Investment activity
2018–2025 · 7 investments
Recent (last 2 years)Earlier
